Pancreatic Cancer Research

ResearcherKarolinska University HospitalActive in the last 2 years

Miroslav Vujasinović

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6496-295X; OpenAlex author ID A5067205580. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 3 papers · 2026: 2 papers

Papers 9

  1. Risk of Pancreatic Cancer Associated With Precursor Lesions in Individuals and First-Degree Relatives: A Nationwide Cohort Study. Co-author DOI 10.1016/j.cgh.2026.06.009↗
  2. Association between pancreatic enzyme replacement therapy and mortality in pancreatic cancer: a matched case-control study. Last author DOI 10.1016/j.pan.2025.12.008↗
  3. Performance of MRI-based surveillance for high-risk individuals for pancreatic cancer. First author DOI 10.1016/j.ejrad.2025.112275↗
  4. Exploring the psychological burden in a pancreatic cancer surveillance programme based on high-risk individuals: a Swedish cross-sectional study. Co-author DOI 10.1136/bmjopen-2024-097814↗
  5. Risk of Pancreatic Cancer in Inflammatory Pancreatic Diseases. First author DOI 10.4166/kjg.2025.019↗
  6. Can our experience with surveillance for inherited pancreatic cancer help to identify early pancreatic cancer in the general population? Co-author DOI 10.1007/s10689-024-00363-6↗
  7. Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review. Co-author DOI 10.1016/j.pan.2021.03.007↗
  8. Risk of Developing Pancreatic Cancer in Patients with Chronic Pancreatitis. Co-author DOI 10.3390/jcm9113720↗
  9. Pancreatic Exocrine Insufficiency in Pancreatic Cancer. Co-author DOI 10.3390/nu9030183↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Matthias J. Löhr · 9 shared papers, 2017–2026 · strength 2.14
  2. Poya Ghorbani · 3 shared papers, 2020–2026 · strength 0.66
  3. Patrick Maisonneuve · 2 shared papers, 2020–2025 · strength 0.52
  4. Ana Dugic · 2 shared papers, 2020–2026 · strength 0.39
  5. Raffaella Pozzi Mucelli · 2 shared papers, 2020–2025 · strength 0.37
  6. Chen Yuan · 1 shared paper, 2026 · strength 0.33
  7. Jonas Filip Ludvigsson · 1 shared paper, 2026 · strength 0.33
  8. Qiao-Li Wang · 1 shared paper, 2026 · strength 0.33
  9. Brian Matthew Wolpin · 1 shared paper, 2026 · strength 0.33
  10. Maria Gustafsson Liljefors · 1 shared paper, 2026 · strength 0.29
  11. Ebba Asplund · 1 shared paper, 2025 · strength 0.28
  12. Anna Vesterberg · 1 shared paper, 2025 · strength 0.28
  13. Carlos Fernández Moro · 1 shared paper, 2025 · strength 0.27
  14. Nikolaos Kartalis · 1 shared paper, 2025 · strength 0.27
  15. Malin Sund · 1 shared paper, 2024 · strength 0.24
  16. Daniel Öhlund · 1 shared paper, 2024 · strength 0.24
  17. Marco Del Chiaro · 2 shared papers, 2017–2021 · strength 0.20
  18. Roberto Valente · 2 shared papers, 2017–2020 · strength 0.19
  19. Kensuke Kubota · 1 shared paper, 2021 · strength 0.11
  20. Itaru Naitoh · 1 shared paper, 2021 · strength 0.11
  21. Tsukasa Ikeura · 1 shared paper, 2021 · strength 0.11
  22. Petr Dítě · 1 shared paper, 2021 · strength 0.11
  23. Terumi Kamisawa · 1 shared paper, 2021 · strength 0.11
  24. Tomáš Hucl · 1 shared paper, 2021 · strength 0.11
  25. Peter Mačinga · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.